Patrick Trucchio
Stock Analyst at H.C. Wainwright
(4.97)
# 84
Out of 4,978 analysts
1114
Total ratings
58.1%
Success rate
38.1%
Average return
Main Sectors:
Stocks Rated by Patrick Trucchio
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGMB AgomAb Therapeutics NV | Reiterated: Buy | $35 | $12.22 | +186.42% | 4 | Sep 15, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $70 | $36.82 | +90.11% | 46 | Sep 15, 2026 | |
| ASMB Assembly Biosciences | Reiterated: Buy | $50 | $26.11 | +91.50% | 16 | Sep 9, 2026 | |
| BEAM Beam Therapeutics | Reiterated: Buy | $80 | $23.22 | +244.53% | 30 | Sep 9, 2026 | |
| PHVS Pharvaris | Reiterated: Buy | $60 | $38.06 | +57.65% | 11 | Sep 9, 2026 | |
| ALNY Alnylam Pharmaceuticals | Reiterated: Buy | $455 | $238.27 | +90.96% | 78 | Sep 2, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Reiterated: Buy | $120 | $70.67 | +69.80% | 73 | Sep 1, 2026 | |
| IVVD Invivyd | Reiterated: Buy | $10 | $0.83 | +1,104.82% | 40 | Sep 1, 2026 | |
| VYGR Voyager Therapeutics | Reiterated: Buy | $25 | $3.09 | +709.06% | 29 | Aug 27, 2026 | |
| GOSS Gossamer Bio | Reiterated: Buy | $2 | $10.38 | -80.73% | 51 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $3.40 | +1,223.53% | 13 | Aug 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $145 | $60.22 | +140.78% | 15 | Aug 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $1.17 | +754.70% | 8 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $5 | $0.78 | +541.03% | 51 | Aug 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $55 | $30.25 | +81.82% | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $3.23 | +519.20% | 50 | Aug 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $75 | $12.46 | +501.93% | 43 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $6.61 | +807.72% | 67 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $55 | $42.17 | +30.42% | 28 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $31.78 | +214.71% | 53 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 | $35.37 | +69.64% | 3 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $4.99 | +902.00% | 22 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $27.55 | +135.93% | 40 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.44 | +91.57% | 67 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $70 → $65 | $13.81 | +370.67% | 61 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $80 | $43.10 | +85.61% | 62 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.1473 | - | 51 | Jun 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 → $10 | $0.9277 | n/a | 34 | Apr 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $360 | $11.17 | n/a | 14 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $11.05 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.05 | n/a | 5 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 100p → 46p | 5p | n/a | 3 | Nov 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | €33.00 | €2.81 | n/a | 10 | Mar 27, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $66 → $24 | $41.28 | n/a | 2 | Nov 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 → $130 | $12.29 | n/a | 3 | Sep 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $117 → $72 | $13.56 | n/a | 2 | Nov 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $22 | $20.84 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $25 | $4.06 | n/a | 1 | Apr 19, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $125 | $98.68 | n/a | 1 | Dec 23, 2014 |
AgomAb Therapeutics NV
Sep 15, 2026
Reiterated: Buy
Price Target: $35
Current: $12.22
Upside: +186.42%
Definium Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $70
Current: $36.82
Upside: +90.11%
Assembly Biosciences
Sep 9, 2026
Reiterated: Buy
Price Target: $50
Current: $26.11
Upside: +91.50%
Beam Therapeutics
Sep 9, 2026
Reiterated: Buy
Price Target: $80
Current: $23.22
Upside: +244.53%
Pharvaris
Sep 9, 2026
Reiterated: Buy
Price Target: $60
Current: $38.06
Upside: +57.65%
Alnylam Pharmaceuticals
Sep 2, 2026
Reiterated: Buy
Price Target: $455
Current: $238.27
Upside: +90.96%
Arrowhead Pharmaceuticals
Sep 1, 2026
Reiterated: Buy
Price Target: $120
Current: $70.67
Upside: +69.80%
Invivyd
Sep 1, 2026
Reiterated: Buy
Price Target: $10
Current: $0.83
Upside: +1,104.82%
Voyager Therapeutics
Aug 27, 2026
Reiterated: Buy
Price Target: $25
Current: $3.09
Upside: +709.06%
Gossamer Bio
Aug 26, 2026
Reiterated: Buy
Price Target: $2
Current: $10.38
Upside: -80.73%
Aug 26, 2026
Reiterated: Buy
Price Target: $45
Current: $3.40
Upside: +1,223.53%
Aug 21, 2026
Reiterated: Buy
Price Target: $145
Current: $60.22
Upside: +140.78%
Aug 20, 2026
Reiterated: Buy
Price Target: $10
Current: $1.17
Upside: +754.70%
Aug 20, 2026
Reiterated: Buy
Price Target: $10 → $5
Current: $0.78
Upside: +541.03%
Aug 18, 2026
Reiterated: Buy
Price Target: $50 → $55
Current: $30.25
Upside: +81.82%
Aug 17, 2026
Reiterated: Buy
Price Target: $20
Current: $3.23
Upside: +519.20%
Aug 14, 2026
Reiterated: Buy
Price Target: $75
Current: $12.46
Upside: +501.93%
Aug 12, 2026
Reiterated: Buy
Price Target: $60
Current: $6.61
Upside: +807.72%
Aug 12, 2026
Reiterated: Buy
Price Target: $55
Current: $42.17
Upside: +30.42%
Aug 12, 2026
Reiterated: Buy
Price Target: $100
Current: $31.78
Upside: +214.71%
Aug 11, 2026
Reiterated: Buy
Price Target: $60
Current: $35.37
Upside: +69.64%
Aug 10, 2026
Reiterated: Buy
Price Target: $50
Current: $4.99
Upside: +902.00%
Aug 10, 2026
Reiterated: Buy
Price Target: $65
Current: $27.55
Upside: +135.93%
Aug 10, 2026
Reiterated: Buy
Price Target: $20
Current: $10.44
Upside: +91.57%
Aug 7, 2026
Reiterated: Buy
Price Target: $70 → $65
Current: $13.81
Upside: +370.67%
Jul 30, 2026
Reiterated: Buy
Price Target: $80
Current: $43.10
Upside: +85.61%
Jun 9, 2026
Rated: Hold
Price Target: n/a
Current: $0.1473
Upside: -
Apr 2, 2025
Reiterated: Buy
Price Target: $25 → $10
Current: $0.9277
Upside: n/a
May 15, 2023
Reiterated: Buy
Price Target: $20 → $360
Current: $11.17
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $11.05
Upside: n/a
Feb 10, 2023
Rated: Hold
Price Target: n/a
Current: $0.05
Upside: n/a
Nov 2, 2022
Reiterated: Buy
Price Target: 100p → 46p
Current: 5p
Upside: n/a
Mar 27, 2020
Reiterated: Buy
Price Target: €33.00
Current: €2.81
Upside: n/a
Nov 8, 2019
Downgraded: Hold
Price Target: $66 → $24
Current: $41.28
Upside: n/a
Sep 18, 2019
Reiterated: Buy
Price Target: $120 → $130
Current: $12.29
Upside: n/a
Nov 13, 2018
Downgraded: Hold
Price Target: $117 → $72
Current: $13.56
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $22
Current: $20.84
Upside: n/a
Apr 19, 2018
Initiated Coverage: Buy
Price Target: $25
Current: $4.06
Upside: n/a
Dec 23, 2014
Upgraded: Buy
Price Target: $125
Current: $98.68
Upside: n/a